Tsuchiya, T., Imanaka, K., Iwaki, Y., Oyama, R., Hashine, K., Yamaguchi, A., & Uemura, H. (2019). An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol.
Dyfyniad Arddull ChicagoTsuchiya, Tomohiro, Keiichiro Imanaka, Yuki Iwaki, Ryo Oyama, Katsuyoshi Hashine, Akito Yamaguchi, and Hiroji Uemura. "An Open-label, Phase 1 Study of Androgen Receptor Antagonist, Apalutamide in Japanese Patients With Metastatic Castration-resistant Prostate Cancer." Int J Clin Oncol 2019.
Dyfyniad MLATsuchiya, Tomohiro, et al. "An Open-label, Phase 1 Study of Androgen Receptor Antagonist, Apalutamide in Japanese Patients With Metastatic Castration-resistant Prostate Cancer." Int J Clin Oncol 2019.